This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

A Path Through the Forest - The Role of Agency Guidance in Developing Regulatory Compliance Programs

Abstract

Counsel involved in developing regulatory compliance programs know that merely looking at the statute and regulations is not enough. They need to look to multiple sources of information to determine how the agency interprets the laws and regulations, and to understand agency expectations. Agency guidance documents play an important role in obtaining this information. This paper identifies the types of materials available and how they can be used. It also touches on the problems with these materials, including their nonbinding nature, and the benefits of using them.

PLS LogoCopyright & permissions

Author

Portrait image of Jack Sorokin
Jack Sorokin
Adjunct Instructor, Fremont College, USA

Jack Sorokin has had extensive experience as regulatory affairs counsel, most recently as Deputy General Counsel for Beckman Coulter, Inc., a leading international manufacturer and marketer of biomedical testing instrument systems, tests and supplies that simplify, automate and innovate complex laboratory processes. His practice has covered the range of regulatory issues, including medical device, environmental, occupational safety and health, hazardous materials, controlled substance, and transportation. His practice has also included corporate law and governance, SEC compliance, finance, risk management, supply chain, manufacturing, real estate, procurement, and import/export law. He retired from Beckman Coulter in June, 2012 and is currently an Instructor in the Fremont College Paralegal Studies Program.

Company

Fremont College

Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. The Company's diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use Beckman Coulter's life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. More than 275,000 Beckman Coulter systems operate in both diagnostics and life sciences laboratories on six continents

Related Papers

Implementing Effective Compliance Programs in Jurisdictions Where the Rule of Law is Weak
Multinational organizations increasingly operate in jurisdictions where the rule of law is weak, inconsistently enforced, or subject to political and economic influence. For pharmaceutical and biotechnology companies, these environments present...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Valentina Lacerca-Allen
Valentina Lacerca-Allen
Title Marketing/ Communication Specialist, Ethiprax LLC., USA
The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer's Perspective
The intersection between the health care fraud and abuse laws and pharmaceutical marketing practices in the U.S. raises interesting compliance issues for pharmaceutical manufacturers, particularly in light of the newly...Read more
Portrait image of Leslie Restaino
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
Corporate Compliance in a Fragmented Regulatory Landscape
As multinational companies expand into diverse and rapidly evolving markets, legal and compliance teams face increasing pressure to navigate fragmented regulatory frameworks while upholding consistent global standards. This paper draws...Read more
Portrait image of Moutaz Abdullat
Moutaz Abdullat
General Counsel, Fererro , UAE
March-In Rights at a Crossroad: What Biopharma Needs To Know Under Trump Administration
Few pieces of legislation have shaped the modern innovation landscape as profoundly as the Bayh-Dole Act of 1980. By allowing universities, small businesses, and non-profit organizations to retain ownership...Read more
Portrait image of Joanna Brougher
Joanna Brougher
Owner & Principal, BioPharma Law Group PLLC, USA
Portrait image of Bhavya Bhardwaj
Bhavya Bhardwaj
Student, University of Pennsylvania, USA